Reported Earlier, Orchestra BioMed Prices $75M Public Offering Of 15M Common Shares At $5.00 Per Share To Fund AVIM Therapy And Virtue SAB Programs
Share
Why It Matters
Orchestra BioMed is selling 15 million new shares for $75 million total. They will use the money to pay for two medicine programs they are working on.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.